Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_assertion type Assertion NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_head.
- NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_assertion description "[However, the introduction in the model of the HPA-1 and HPA-2 genotypes as interaction terms led to a significant improvement in the prediction of PR, although the quantitative effect was small (about 3% improvement, P=0.046).Thus, in CAD patients, there seems to be only a mild effect of the platelet glycoprotein HPA-1 and HPA-2 polymorphisms on collagen-adenosine diphosphate-stimulated PR after the effect of well-established clinical and biochemical determinants are considered.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_provenance.
- NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_assertion evidence source_evidence_literature NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_provenance.
- NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_assertion SIO_000772 15741796 NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_provenance.
- NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_assertion wasDerivedFrom befree-2016 NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_provenance.
- NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_assertion wasGeneratedBy ECO_0000203 NP483393.RAjEnGz1Ay1WIrCbncfiQltGyz3jVx382q_lM8S1uJxGo130_provenance.